GlobalData on MSN21d
FDA approves Medtronic’s Affera mapping and ablation system with Sphere-9 catheter
This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.
stockhead4d
Dr Boreham’s Crucible: Transforming the cardiac ablation market takes ticker… and time
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...
FierceBiotech21d
FDA approves Medtronic's Affera all-in-one pulsed field ablation system
Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has ... isthmus-dependent atrial flutter. "The Affera system was designed to address ...
WLWT1mon
LA Chargers head coach Jim Harbaugh to wear heart monitor for two weeks after leaving Sunday’s game with ‘atrial flutter’
A cardiac ablation is a treatment for irregular heartbeats ... weeks after leaving his team's game on Sunday with an "atrial flutter." Harbaugh left the sideline during the first quarter of ...
Yahoo Finance23d
A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.
Boston Scientific resumes enrolment in pulsed field ablation trial
Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...
FierceBiotech8d
J&J MedTech secures FDA approval for Varipulse pulsed field ablation system
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
Medtronic Gets FDA Approval for Affera Technology
Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.
Stockhouse22d
A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera(TM) Mapping and Ablation System and Sphere-9(TM) Catheter
and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.